Preferred Name |
doconexent |
|
Synonyms |
docosahexaenoic acid n-3 |
|
Definitions |
A polyunsaturated very long-chain fatty acid with a 22-carbon backbone and 6 double bonds, originating from the 3rd, 6th, 9th, 12th, 15th and 18th positions from the methyl end. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C68346" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68346" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000776105 |
|
altLabel |
docosahexaenoic acid n-3 fatty acid 22:6 n-3 DHA (all-Z)-4,7,10,13,16,19-docosahexaenoic acid cis-4,7,10,13,16,19-docosahexaenoic acid |
|
CAS Registry |
6217-54-5 |
|
cui |
C2348308 C0556150 |
|
DATE FIRST PUBLISHED |
2015-10-06 |
|
Date last modified |
2015-10-06 |
|
definition |
A polyunsaturated very long-chain fatty acid with a 22-carbon backbone and 6 double bonds, originating from the 3rd, 6th, 9th, 12th, 15th and 18th positions from the methyl end. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C68346" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68346" NCI Thesaurus) |
|
NCI ID |
C68346 |
|
notation |
CDR0000776105 |
|
ORIG STY |
Drug/agent |
|
prefLabel |
doconexent |
|
tui |
T109 T123 T121 |